ResiQuant | $4,000,000 | (Mar 19, 2025)
Curevo Vaccine | $110,000,000 | (Mar 19, 2025)
Gradial | $13,000,000 | (Mar 19, 2025)
Certified by Founder
Lodge
MSInsight
start up
France
- Paris
- 11/03/2025
- Seed
- $1,735,762
MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status.
MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker.
We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for guiding clinical decision-making.
- Industry Medical Equipment Manufacturing
- Website https://www.msinsight.tech/
- LinkedIn https://www.linkedin.com/company/msinsight/
Madison Scientific Inc | $7,000,000 | (Mar 19, 2025)
Equipt.ai | $3,200,000 | (Mar 19, 2025)
VIA(US) | $28,000,000 | (Mar 19, 2025)
brain.space | $11,000,000 | (Mar 19, 2025)
Mito Health (YC S24) | $2,200,000 | (Mar 19, 2025)
Arcade.dev | $12,000,000 | (Mar 19, 2025)
Orion Security | $6,000,000 | (Mar 19, 2025)
Rakurai | $3,000,000 | (Mar 18, 2025)
Darwin AI | $5,000,000 | (Mar 18, 2025)